Publication | Open Access

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Rare DiseasesUrologyClinical TrialsDegenerative DiseaseRehabilitationMedicineNeuromusculoskeletal DisorderAct Dmd